Skip to content

Company information lookup

VIRAX HOLDINGS LIMITED (VHL)

Bio-pharmaceutical research and development investment.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
VHL 0.005 -16.67% 0.005 0.006 0.005 0.005 0.005 1,000,000

VIRAX HOLDINGS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code VHL
Securities
Official Listing Date 19 December, 1986
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.virax.com.au
Registered Office Address C/- FJH Solutions, 21 Teddington Road, BURSWOOD, WA, AUSTRALIA, 6100
Head Office Telephone (08) 9486 2333
Head Office Fax (08) 9355 4580
Share Registry AUTOMIC REGISTRY SERVICES
LEVEL 1, 7 VENTNOR AVENUE, WEST PERTH, WA, AUSTRALIA, 6005
Share Registry Telephone (08) 9324 2099
Directors / Senior Management
Dr Wayne A Millen (Chairman)
Dr Robert Crombie (Managing Director)
Mr Paul Edward Hopper (Executive Director)
Mr Roland Toder (Non Exec. Director)
Mr Brendan de Kauwe (Non Exec. Director)
Company Secretary Mr Sean Henbury
Principal Activities Bio-pharmaceutical research and development investment.

VIRAX HOLDINGS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
09/09/2014 asterix FDA IND Re-Activation Request for Phase Ib/II Trial 2 PDF
01/09/2014 asterix Virax Holdings Appendix 4E and 2014 Financial Report 67 PDF
31/07/2014 asterix Appendix 4C - quarterly 5 PDF
23/07/2014   Investor Roadshow Presentation 18 PDF
21/07/2014   Cancer Authority to help Steer US Breast Cancer Progam 2 PDF
24/06/2014   Initial Director's Interest Notice 2 PDF
23/06/2014   VHL appoints Ground Zero Pharmaceuticals 2 PDF
16/06/2014   New MD to Present at International Life Sciences Showcase 2 PDF
06/06/2014   Initial Director's Interest Notice 2 PDF
30/05/2014 asterix VHL completes Pathway acquisiton, appoints new director 2 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
11 Sep 2014 0.006 0% 0.006 0.006 1,495,000
09 Sep 2014 0.006 20% 0.006 0.005 9,980,671
08 Sep 2014 0.005 -16.67% 0.006 0.005 325,000
04 Sep 2014 0.006 0% 0.006 0.006 100,000
03 Sep 2014 0.006 0% 0.006 0.006 2,360,920

* Volume of shares shown represents only those shares traded on ASX.

VIRAX HOLDINGS LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security VHL. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security VHL

Warrants & Structured Products

No warrants & Structured Products are available over the security VHL

ASX CFDs

No Contracts For Differences are available over the security VHL